Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2009 Jun 3;4(6):e5784. doi: 10.1371/journal.pone.0005784.

Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort.

Author information

1
Bristol Genetic Epidemiology Laboratories (BGEL), Department of Social Medicine, University of Bristol, Bristol, UK. santi.rodriguez@bristol.ac.uk

Abstract

BACKGROUND:

Filaggrin is a major protein in the epidermis. Several mutations in the filaggrin gene (FLG) have been associated with a number of conditions. Filaggrin is expressed in the tympanic membrane and could alter its mechanical properties, but the relationship between genetic variation in FLG and hearing has not yet been tested.

METHODOLOGY/PRINCIPAL FINDINGS:

We examined whether loss-of function mutations R501X and 2282del4 in the FLG gene affected hearing in children. Twenty eight hearing variables representing five different aspects of hearing at age nine years in 5,377 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort were tested for association with these mutations. No evidence of association was found between R501X or 2282del4 (or overall FLG mutation carrier status) and any of the hearing phenotypes analysed.

CONCLUSIONS/SIGNIFICANCE:

In conclusion, carrier status for common filaggrin mutations does not affect hearing in children.

PMID:
19492053
PMCID:
PMC2685991
DOI:
10.1371/journal.pone.0005784
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center